Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Earning access to the world's biggest market. Down 5%. Reminds me of the old ketchup commercial. M-A-N-I-P-U-L-AAA-T-I-O-N.
Day traders. Buying in the 60s, selling in the 70s. 10 cent profit on 100k shares is a nice days work
Judge Du made tragic errors. Hopefully when she has health issues she uses the generics. What I don't understand is why the FDA doesn't require follow up studies to prove that generics are the bio therapeutic equivalent of the approved drug.. in the case of V, bio equivalent may not equal bio therapeutic equivalence
North, what is your assessment of the recent developments. You have consistently had the best incite. Thanks
Guys. I have been on this board years before your first post. I am very long for a long time and hope all works out well. You are acting foolishly if you are not prepared
I am beginning to question your motivation
Seve, You know the boy scout motto.
Why would you say BS? The stock has done nothing but go down. Without a turn around event it could even receive a delisting notice. Management may have no choice but to reverse split
seve , if nothing substantial occurs I estimate the stock will be a reverse split somewhere between. 47 - .58 . The split will be a minimum of 10-1 and possible as high as
20-1. We need strong news / performance to stop the day trading short freight train. Gltal
Amrn is now in the rinse and repeat cycle. Shorts are buying large amounts and scooping up nicks every day. The next move will be a reverse split (around $5-6) after which they will pursue the same strategy
Amrn will have 1 opportunity to defeat this onslaught. Europe and China must show explosive growth and a successful US strategy must be implemented. And hopefully one of the trials produce positive results.Barring these actions, we will spiral down. I am long and have been for many years.
Amrn is now headed into a manipulation cycle. It's cheap enough for the daily manipulators to purchase 100k shares or more and trade it for just a few pennies profit. Then rinse and repeat. It will take some major news to break the cycle. Good. Luck to all longs
Dinner played hard ball with the amrn board. I believe his original goal of obtaining 3 seats was his ideal position. He could influence all major decisions and a final sale without doing day to day operational chores. His takeover of the BOD falls under the category of Be Careful What You Wish For.
Did I read the amrn release correctly. They are seeking approval for 150,000,000 performance shares???
KM had every opportunity too work with Sarissa. Ego is a bitch. He should receive little to no additional compensation. His voluntary decision to leave
The presentation today was business as usual. Does anyone think Roche, Novo,Bayer, Sanofi etc. Would have the same problems gaining final pricing/approvals in Germany or elsewhere.
Downtown please post the process for voting w fidelity. When the rep gets back to you
North, as you suggested there is something different between V and the generics. Generics may be bioequivalent but are not therapeutic equivalent. The FDA has missed something in the approval process. I don't k own enough molecular biology, but there needs to be a requirement for the generics to prove that work as well as V.
Liz, was in ireland last week. Cliffs were #1. But don't miss giants causeway.
When does European patent expire?
Question. Do the commonwealth countries tie into the UK recommendations in any way?
North, verve has an interesting technology that theoretically turns off certain liver proteins . They are probably 3-5 years away (if all goes well) from a finished , approved product. They have just started 1b study.
It's not the journalism degree I have a problem with. It's the criminal activity he uses his talents for. Check out his previous conviction when he worked for Cramer.
Someone on another board floated a conspiracy theory that amrn wants the fda to review tries results and cancell approval, leaving only the mace results. This would eliminate all generic competition. Crazy or crazy like a fox.
Any Supreme Court Justice who does not ask a single question in any case before the court for more than 10 years is at best incompetent.
Any Supreme Court Justice who doesn't ask a question in any case before the court for more than a decade is at best incompetent.
I still find it hard to believe that the fda does not require a follow up study to prove therapeutic equivalency after they approve a generic such as GV.
Marjan. Either way. He'll of an effort.
Mr. Main. I think we can find 11,000 investors to bid up the price
Zip. I would prefer to wait also. Just trying to look into the crystal ball. Someone like Goldman may convince them to reverse split and maybe issue a few more shares for the EU launch. They are always looking for a quick commission.
Kiwi take a look at Arena pharma history. Worked very well. Allows institutions to buy if over $5.
Watch for a stock reverse split to make the stock more presentable.
Watch for a stock split to make the stock more presentable.
AVii I know you're out there. What did you think of the statistical analysis
4 things that will salvage this stock
- Europe will approve V
- China franchise will be sold for cash and a royalty (to a Chinese company with clout in that market)
- V will control U.S. market with a generic offering (they control raw materials)
- Combination drug (statin + V) will complete development within 12 months
Stock will climb back to double digits, but it will be a hand wringing 12-18 months, as usual. Stock is a bargain at 1.40. It's basically an option, with no time limit.
Is this a totally dumb idea? What would it cost in time and money to run a small study showing that generics are not the bipequovalent of vaskepa?
Well we've now heard from the pro- Russian contingent and the conspiracy theorists. Maybe we should ask what Amrn management should be doing better. China and EU are enormous markets with great potential. How do we capture our share?
Invest, note that lynas is now in u.s., hired by the Pentagon for a start up. Like mp also.
Invest, take a look at China's hold on rate earth metals. If you agree it's am issue, take a look at Lynas.
Can we expect a formal written opinion from the court documenting their legal reasoning, or is this release all we're entitled to?
North, did Du Set new legal precedent by weighing secondary factors against each other to reach a conclusion? Will the court ignore this in their deliberations
What ever happened to the argument that Du incorrectly weighed wind
Secondary points against each other